Leaflet CREDANIL 250mg / 25mg tablets

Product code:
W03949003
Quantity:
20
Indicated for:
Parkinson's disease
Route of administration:
oral
Substance:
levodopa + carbidopa (antiparkinsonian agents)
ATC
N04BA02 — Nervous system | Dopaminergic agents | Dopa and dopa derivatives

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Levodopa + Carbidopa is a combination medication used in the treatment of Parkinson's disease and parkinsonian syndromes. Levodopa is a precursor of dopamine, which helps compensate for the dopamine deficiency in the brain characteristic of these conditions. Carbidopa is a peripheral decarboxylase inhibitor that prevents levodopa from being converted into dopamine outside the brain, increasing the amount of levodopa that reaches the brain and reducing side effects such as nausea.

This combination is effective in alleviating symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and balance difficulties. The medication is usually administered in gradually adjusted doses to minimize side effects and optimize benefits.

Side effects may include nausea, dizziness, drowsiness, motor fluctuations (such as 'on-off' phenomena), or, in rare cases, hallucinations and mood changes. It is important to take the medication as prescribed by a doctor, with regular monitoring to adjust doses based on the progression of the disease.

General data about CREDANIL 250mg / 25mg

Substance:
levodopa + carbidopa
Date of latest medicines list:
01-07-2014
Product code:
W03949003
Concentration:
250mg / 25mg
Pharmaceutical form:
tablets
Quantity:
20
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Pharmaceutical forms available for levodopa + carbidopa

Concentrations available for levodopa + carbidopa

  • 100mg/25mg
  • 2000mg/500mg
  • 200mg/50mg
  • 20mg/5mg/ml
  • 250mg/25mg

Combinations with other substances